Substance / Medication

Cefalexin anhydrous

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

14 trials linked to this intervention

14
Total Trials
1
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Phage Therapy in Bacterial Pneumonia Models: A Systematic Review and Meta-Analysis.
Rahman Mohammad Akhlaquer, Verma Kapil Kumar, Posa Mahesh Kumar · Comb Chem High Throughput Screen · 2025
PMID: 38357944Meta-Analysis
Prevention of renal stone disease recurrence. A systematic review of contemporary pharmaceutical options.
Sfoungaristos Stavros, Gofrit Ofer N, Yutkin Vladimir et al. · Expert Opin Pharmacother · 2015
PMID: 25881654Meta-Analysis
Strategy to control catheter encrustation with citrated drinks: a randomized crossover study.
Khan Azhar, Housami Fadi, Melotti Roberto et al. · J Urol · 2010
PMID: 20171661RCT
The Brief Case: Proteus mirabilis Causing Coraliform Lithiasis and Bacteremia in an Elderly Catheterized Patient.
Maldonado-Barrueco Alfredo, Grandioso-Vas David, Rico-Nieto Alicia et al. · J Clin Microbiol · 2022
PMID: 36259775ReviewFull text (PMC)
Closing Brief Case: Proteus mirabilis Causing Coraliform Lithiasis and Bacteremia in an Elderly Catheterized Patient.
Maldonado-Barrueco Alfredo, Grandioso-Vas David, Rico-Nieto Alicia et al. · J Clin Microbiol · 2022
PMID: 36259776ReviewFull text (PMC)
Pathogenesis of Proteus mirabilis in Catheter-Associated Urinary Tract Infections.
Yuan Fei, Huang Ziye, Yang Tongxin et al. · Urol Int · 2021
PMID: 33691318Review
Bacterial biofilm formation on indwelling urethral catheters.
Pelling H, Nzakizwanayo J, Milo S et al. · Lett Appl Microbiol · 2019
PMID: 30811615Review
Pathogenesis ofInfection.
Armbruster Chelsie E, Mobley Harry L T, Pearson Melanie M · EcoSal Plus · 2018
PMID: 29424333ReviewFull text (PMC)
From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis.
Norsworthy Allison N, Pearson Melanie M · Trends Microbiol · 2017
PMID: 28017513ReviewFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cefalexin anhydrous (substance)
SNOMED CT
785690001
UMLS CUI
C2699162

Clinical Data

This intervention maps to 14 entities in the Ltrl knowledge graph.

14
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
14
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.